221 related articles for article (PubMed ID: 31287208)
21. How have pharmacists in different practice settings integrated prescribing privileges into practice in Alberta? A qualitative exploration.
Guirguis LM; Makowsky MJ; Hughes CA; Sadowski CA; Schindel TJ; Yuksel N
J Clin Pharm Ther; 2014 Aug; 39(4):390-8. PubMed ID: 24805908
[TBL] [Abstract][Full Text] [Related]
22. Pharmacist independent prescribing in critical care: results of a national questionnaire to establish the 2014 UK position.
Bourne RS; Whiting P; Brown LS; Borthwick M
Int J Pharm Pract; 2016 Apr; 24(2):104-13. PubMed ID: 26420309
[TBL] [Abstract][Full Text] [Related]
23. Collaborative prescribing: a qualitative exploration of a role for pharmacists in mental health.
Wheeler A; Crump K; Lee M; Li L; Patel A; Yang R; Zhao J; Jensen M
Res Social Adm Pharm; 2012; 8(3):179-92. PubMed ID: 21831724
[TBL] [Abstract][Full Text] [Related]
24. The role of the pharmacist in palliative care: results of a survey conducted in Australia and Canada.
Gilbar P; Stefaniuk K
J Palliat Care; 2002; 18(4):287-92. PubMed ID: 12611320
[TBL] [Abstract][Full Text] [Related]
25. The accessibility of pharmacist prescribing and impacts on medicines access: A systematic review.
Walpola RL; Issakhany D; Gisev N; Hopkins RE
Res Social Adm Pharm; 2024 May; 20(5):475-486. PubMed ID: 38326207
[TBL] [Abstract][Full Text] [Related]
26. A systematic review of pharmacist input to metabolic syndrome screening, management and prevention.
Al AdAwi RM; Stewart D; Ryan C; Tonna AP
Int J Clin Pharm; 2020 Aug; 42(4):995-1015. PubMed ID: 32607719
[TBL] [Abstract][Full Text] [Related]
27. Design of the POINT study: Pharmacotherapy Optimisation through Integration of a Non-dispensing pharmacist in a primary care Team (POINT).
Hazen AC; Sloeserwij VM; Zwart DL; de Bont AA; Bouvy ML; de Gier JJ; de Wit NJ; Leendertse AJ
BMC Fam Pract; 2015 Jul; 16():76. PubMed ID: 26135582
[TBL] [Abstract][Full Text] [Related]
28. Pharmacist supplementary prescribing: a step toward more independence?
Dawoud D; Griffiths P; Maben J; Goodyer L; Greene R
Res Social Adm Pharm; 2011 Sep; 7(3):246-56. PubMed ID: 21272547
[TBL] [Abstract][Full Text] [Related]
29. Pharmacists' involvement in and attitudes toward pharmacy practice research: A systematic review of the literature.
Awaisu A; Alsalimy N
Res Social Adm Pharm; 2015; 11(6):725-48. PubMed ID: 25698363
[TBL] [Abstract][Full Text] [Related]
30. Factors influencing secondary care pharmacist and nurse independent prescribers' clinical reasoning: An interprofessional analysis.
Abuzour AS; Lewis PJ; Tully MP
J Interprof Care; 2018 Mar; 32(2):160-168. PubMed ID: 29190157
[TBL] [Abstract][Full Text] [Related]
31. Barriers and facilitators to implementation of non-medical independent prescribing in primary care in the UK: a qualitative systematic review.
Edwards J; Coward M; Carey N
BMJ Open; 2022 Jun; 12(6):e052227. PubMed ID: 35676011
[TBL] [Abstract][Full Text] [Related]
32. "Everyone needs to understand each other's systems": Stakeholder views on the acceptability and viability of a Pharmacist Independent Prescriber role in care homes for older people in the UK.
Lane K; Bond C; Wright D; Alldred DP; Desborough J; Holland R; Hughes C; Poland F
Health Soc Care Community; 2020 Sep; 28(5):1479-1487. PubMed ID: 32124516
[TBL] [Abstract][Full Text] [Related]
33. The pharmacist as prescriber: a discourse analysis of newspaper media in Canada.
Schindel TJ; Given LM
Res Social Adm Pharm; 2013; 9(4):384-95. PubMed ID: 22835707
[TBL] [Abstract][Full Text] [Related]
34. A qualitative study of UK pharmacy pre-registration graduates' views and reflections on pharmacist prescribing.
McIntosh T; Stewart D
Int J Pharm Pract; 2016 Apr; 24(2):139-41. PubMed ID: 26450769
[TBL] [Abstract][Full Text] [Related]
35. Targeting suboptimal prescribing in the elderly: a review of the impact of pharmacy services.
Castelino RL; Bajorek BV; Chen TF
Ann Pharmacother; 2009 Jun; 43(6):1096-106. PubMed ID: 19470856
[TBL] [Abstract][Full Text] [Related]
36. Implementation of additional prescribing authorization among oncology pharmacists in Alberta.
Au B; Dersch-Mills D; Ghosh S; Jupp J; Chambers C; Cusano F; Danilak M
J Oncol Pharm Pract; 2019 Apr; 25(3):584-598. PubMed ID: 29338572
[TBL] [Abstract][Full Text] [Related]
37. Improving the appropriateness of prescribing in older patients: a systematic review and meta-analysis of pharmacists' interventions in secondary care.
Walsh KA; O'Riordan D; Kearney PM; Timmons S; Byrne S
Age Ageing; 2016 Mar; 45(2):201-9. PubMed ID: 26755524
[TBL] [Abstract][Full Text] [Related]
38. The Foundation Pharmacist Project: exploring new models of dual-sector postgraduate pharmacy training.
Rathbone AP; Rokib T; Baqir W; Campbell D
Int J Pharm Pract; 2019 Apr; 27(2):191-200. PubMed ID: 30088296
[TBL] [Abstract][Full Text] [Related]
39. Identifying the perceived training needs for Australian pharmacist prescribers.
Hoti K; Hughes J; Sunderland B
Int J Pharm Pract; 2014 Feb; 22(1):38-46. PubMed ID: 23419013
[TBL] [Abstract][Full Text] [Related]
40. Facilitators and barriers to non-medical prescribing - A systematic review and thematic synthesis.
Graham-Clarke E; Rushton A; Noblet T; Marriott J
PLoS One; 2018; 13(4):e0196471. PubMed ID: 29709006
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
